VU0652835 inhibits the signaling pathway between G-protein-coupled receptors (GPCRs) and G proteins. It targets mGlu5.
Molecular Weight
333.41
Molecular Formula
C16H19N3O3S
Targets
mGlu5: 81 nM
Form
Lyophilized powder
Purity
>98%
Applications
VU0652835 can be used to research and develop therapeutic strategies for certain diseases that involve excessive activation of GPCR-G protein signaling pathways.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.
